The HSC Conflicts of Interest Office is pleased to announce the implementation of a new system for managing annual conflict of interest disclosures.
The Navex Disclosure Management system will go live for OU Health Sciences at the beginning of February and will be the system of record for all annual HSC employee conflict of interest disclosures.
The Conflicts of Interest Office will be retiring the REDCap system for annual disclosures.
All University employees will be required to complete a new annual disclosure in the Navex system during the month of February, regardless of the date of the employee’s last disclosure submitted in REDCap.
Summary of Changes
-
HSC will transition from REDCap to the Navex Disclosure Management system for employee annual COI disclosures.
-
All employees will be required to complete a new COI disclosure during the month of February 2025.
IMPORTANT NIH: Preparing for 2025 Applications and Review Changes – Tips and Resources
Upcoming "Community Days" on NIH Security Best Practices for Users of Controlled-Access Data
The NIH Office of the Chief Information Officer and the NIH Office of Science Policy are hosting virtual “NIH Community Days” to discuss security best practices for
Approved Users of NIH controlled-access data under the GDS Policy that maintain such data on institutional IT systems and third-party computing infrastructures, ahead of the January 25, 2025,
implementation of updated security standards.
Scheduled for
January 8 and January 10, 2025, from 10 a.m. to 11 a.m. ET, these sessions are open to all researchers and institutional officials who are planning to request or already have access to genomic controlled-access data subject to the NIH Genomic Data Sharing Policy. Registration is required. Please use the links in the flyer for each day of the event to complete registration. ASL will be provided at the events.
The webinars will provide an overview of the new requirements outlined in
NOT-OD-24-157 and related
Frequently Asked Questions, including details on how organizations can comply with the requirements. Participants and their institutions are encouraged to submit questions for the webinars to
gds@mail.nih.gov by December 27, 2024, to ensure answers are available during the informational sessions.
Please assist us in sharing the attached promotional materials with anyone who may be interested in attending.
IMPORTANT ORA Reminder: Completing SoonerTrack II Request Forms for Independent Contractor Agreements (ICA)
Please completely fill out the form. The following items are very important:
-
A Scope of Work (SOW) document specific to the ICA. The document should only include the Scope of Work.
-
Indicate what kind of payment arrangement is being used:
-
Based on Milestones (items in SOW)
-
Flat Fee (one time payment)
-
A Fee Schedule (itemized list of charges)
-
Rate, such as monthly
-
In the Additional Information box please include the contact information where you would like invoices to be sent. The name of the person to email and/or address to mail.
-
Please make sure you have reviewed and correctly answered the items in the Request Form.
Request Forms that are not completed as instructed will be returned.
UPDATE to NIH required Data Management and Sharing Plan language.
Just a reminder that the following language should be included in all NIH DMSPs submitted:
“ The Principal Investigator (PI) for this project, Dr. ABC, will ensure that this Data Management and Sharing (DMS) Plan is followed. The PI will be responsible for oversight of compliance with the accepted DMS Plan. Compliance will be evaluated annually during the award period by [insert name and title of the Authorized Official submitting the application] and progress towards the plan’s DMS activities will be included in the annual Research Performance Progress Report (RPPR) submitted to the National Institute of XXXX Project Officer. At the project conclusion, the final progress report will summarize how the DMS objectives were fulfilled and provide links to the shared dataset(s).”
IMPORTANT REMINDER: NIH Guidance on Communicating and Acknowledging Federal Funding
Recipients should only acknowledge NIH awards on publications and other statements when the activities that contributed to that publication
1) directly arise from the award;
and 2) are within the
scope of the award being acknowledged. When considering whether acknowledgement is necessary, ask yourself:
Did the personnel activity supported by the award contribute to the publication?
Did the award support the conduct of experiments or the analysis of data that contributed to the publication?
Is there a clear and apparent link between the work described in the publication with the aims and objectives of the grant?
If the answer is yes to any of these questions, cite the appropriate NIH support.
Each publication, press release, or other document about research supported by an NIH grant must include:
An acknowledgment of NIH grant support such as: "Research reported in this [publication, release] was supported by [name of the Institute, Center, or other funding component] of the National Institutes of Health under grant number [specific NIH grant number in this format: R01GM012345]."
A disclaimer that says: "The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."
NIH requires recipients to adhere to the requirements of the Steven's Amendment
Public Law 101-166, Section 511, which states that HHS recipients must acknowledge Federal funding when issuing statements, press releases, requests for proposals, bid invitations, and other documents describing projects or programs funded in whole or in part with Federal money. Recipients are required to state 1) the percentage and dollar amounts of the total program or project costs financed with Federal money and (2) the dollar amount of the total costs financed by nongovernmental sources, only for NIH programs that require cost-sharing (NIH GPS 4.2.1).